Transjugular and transseptal treatment of a degenerated mitral valve prosthesis with a balloon-expandable biological valve.
In selected high-risk patients, trans-catheter valve implantation is an emerging therapy for a degenerated bioprosthesis in need of repeated valve replacement. During the last two years, valve-in-valve implantations have mainly been performed in the aortic position and only rarely in the mitral position. Here we describe for the first time the case of a 62 year-old female with severe mitral regurgitation of a degenerated Carpentier Edwards bioprosthesis treated by transjugular, transseptal implantation of a SAPIEN-XT valve. In conclusion this case, together with previous reports, show the feasibility and safety of percutaneous valve-in-valve implantations to treat a degenerated bioprosthesis.
Department of Cardiology, AK St. Georg Hospital, Hamburg, Germany. ul.schaefer@asklepios.com
Ulrich
U
Schaefer
Christian
C
Frerker
Cord
C
Busse
Karl-Heinz
KH
Kuck
D001705:Bioprosthesis; D005260:Female; D006346:Heart Septum / Q000601:surgery; D006350:Heart Valve Prosthesis / Q000009:adverse effects*; D019918:Heart Valve Prosthesis Implantation; D006801:Humans; D007601:Jugular Veins / Q000601:surgery; D008875:Middle Aged; D008943:Mitral Valve / Q000601:surgery*; D008944:Mitral Valve Insufficiency / Q000209:etiology / Q000601:surgery*; D011475:Prosthesis Failure / Q000009:adverse effects*